BASELINE BREAST CANCER RISK DEMOGRAPHICS AND METHODOLOGY FOR THE RALOXIFENE USE FOR THE HEART (RUTH) AND CONTINUING OUTCOMES RELEVANT TO EVISTA (CORE) STUDIES, TWO BREAST CANCER PREVENTION TRIALS

2003 ◽  
Vol 13 (Suppl 1) ◽  
pp. 2.3-2
Author(s):  
M. McNabb ◽  
S. Martino ◽  
R. J. Secrest ◽  
K. Bryant ◽  
J. Blatter ◽  
...  
Breast Care ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. 108-113 ◽  
Author(s):  
Jacqueline Lammert ◽  
Sabine Grill ◽  
Marion Kiechle

Increasing rates of obesity, lack of physical activity, sedentary behavior, and frequent alcohol consumption are major lifestyle-related risk factors for breast cancer. In fact, it has been estimated that about one-third of breast cancer cases are attributable to factors women can change. Most research has focused on examining the impact of one single exposure on breast cancer risk while adjusting for other risk modifiers. Capitalizing on big data, major efforts have been made to evaluate the combined impact of well-established lifestyle factors on overall breast cancer risk. At the individual level, data indicate that even simple behavior modifications could have a considerable impact on breast cancer prevention. Moreover, there is emerging new evidence that adopting a healthy lifestyle may be particularly relevant for women with hereditary susceptibility to breast cancer. On the absolute risk scale, studies suggest that the presence of certain risk factors, such as excessive body weight, had a substantially higher impact on breast cancer risk if women had a hereditary predisposition to cancer. The existing body of knowledge gives the medical professionals guidance as to which factors to focus on when counseling patients. However, well-designed randomized controlled trials utilizing objective methods are crucial to providing concrete recommendations.


2021 ◽  
pp. 1-35
Author(s):  
Inarie Jacobs ◽  
Christine Taljaard-Krugell ◽  
Mariaan Wicks ◽  
Herbert Cubasch ◽  
Maureen Joffe ◽  
...  

Abstract Breast cancer prevention is of great importance to reduce high incidence in South Africa. This study aimed to investigate adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations and the association with breast cancer risk in black urban women from Soweto, South Africa. A total of 396 breast cancer cases and 396 population-based controls from the South African Breast Cancer study (SABC) matched on age and demographic settings was included. Validated questionnaires were used to collect dietary and epidemiological data. To assess adherence to these recommendations, an 8-point adherence score was developed, using tertiles among controls for scoring each recommendation (0, 0.5 and 1) with zero indicating the lowest adherence to the recommendations. Odds ratios and 95% confidence intervals were estimated using multivariate logistic regression models to analyse associations between the WCRF/AICR score and breast cancer risk. Greater adherence (>4.5 vs <3.25) to the 2018 WCRF/AICR Cancer Prevention Recommendations was associated with a significant inverse association with breast cancer risk overall (OR=0.54, 95%CI:0.35-0.91) and specifically in postmenopausal women (OR=0.55, 95%CI:0.34-0.95), in cases with oestrogen positive (ER+) and progesterone positive (PR+) breast cancer subtypes (OR=0.54, 95%CI:0.39-0.89 and OR=0.68, 95%CI:0.43-0.89, respectively), and in obese women (OR=0.52, 95%CI:0.35-0.81). No significant association with breast cancer risk was observed in premenopausal women. Greater adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations may reduce breast cancer risk in this black urban population of Soweto. Adherence thereof should be encouraged and form part of cost-effective breast cancer prevention guidelines.


Lipids ◽  
1992 ◽  
Vol 27 (10) ◽  
pp. 821-826 ◽  
Author(s):  
N. F. Boyd ◽  
M. Cousins ◽  
G. Lockwood ◽  
D. Tritchler

ISRN Oncology ◽  
2013 ◽  
Vol 2013 ◽  
pp. 1-22 ◽  
Author(s):  
Katherine D. Crew

Vitamin D deficiency is a potentially modifiable risk factor that may be targeted for breast cancer prevention and treatment. Preclinical studies support various antitumor effects of vitamin D in breast cancer. Numerous observational studies have reported an inverse association between vitamin D status, including circulating 25-hydroxyvitamin D (25(OH)D) levels, and breast cancer risk. The relationship between vitamin D and mammographic density, a strong predictor of breast cancer risk, remains unclear. Studies analyzing the link between genetic polymorphisms in vitamin D pathway genes and breast cancer incidence and prognosis have yielded inconsistent results. Vitamin D deficiency among breast cancer patients has been associated with poorer clinical outcomes and increased mortality. Despite a number of clinical trials of vitamin D supplementation, the efficacy, optimal dosage of vitamin D, and target blood level of 25(OH)D for breast cancer prevention have yet to be determined. Even with substantial literature on vitamin D and breast cancer, future studies need to focus on gaining a better understanding of the biologic effects of vitamin D in breast tissue. Despite compelling data from experimental and observational studies, there is still insufficient data from clinical trials to make recommendations for vitamin D supplementation for breast cancer prevention or treatment.


Sign in / Sign up

Export Citation Format

Share Document